Management of localized seminoma, stage I-II: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009.

[1]  R. Huddart,et al.  Canadian consensus guidelines for the management of testicular germ cell cancer. , 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[2]  D. Dearnaley,et al.  Surveillance in stage I seminoma patients: a long-term assessment. , 2010, European urology.

[3]  P. Warde,et al.  No role for routine chest radiography in stage I seminoma surveillance. , 2010, European urology.

[4]  A. Horwich,et al.  Testicular seminoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  D. Dearnaley,et al.  Treating IIA/B seminoma with combination carboplatin and radiotherapy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  D. Dearnaley,et al.  Prospective assessment of MRI for imaging retroperitoneal metastases from testicular germ cell tumours. , 2009, Clinical radiology.

[7]  H. Amthauer,et al.  [18F]-FDG-PET in clinical stage I/II non-seminomatous germ cell tumours: results of the German multicentre trial. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  D. Dearnaley,et al.  Evidence-based pragmatic guidelines for the follow-up of testicular cancer: optimising the detection of relapse , 2008, British Journal of Cancer.

[9]  G. Mead,et al.  Relapse patterns in 2,466 stage 1 seminoma patients (pts) entered into Medical Research Council randomised trials , 2008 .

[10]  S. Fosså,et al.  European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I. , 2008, European urology.

[11]  U. Schneider,et al.  Effect of radiotherapy volume and dose on secondary cancer risk in stage I testicular seminoma. , 2008, International journal of radiation oncology, biology, physics.

[12]  W. Brenner,et al.  The role of positron emission tomography in the evaluation of residual masses after chemotherapy for advanced stage seminoma. , 2008, The Journal of urology.

[13]  M. Louwman,et al.  Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  P. Warde,et al.  Evidence‐based guidelines for following stage 1 seminoma , 2007, Cancer.

[15]  P. Abrams,et al.  Evidence--based medicine overview of the main steps for developing and grading guideline recommendations. , 2007, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[16]  P. Hall,et al.  Noncancer causes of death in survivors of testicular cancer. , 2007, Journal of the National Cancer Institute.

[17]  G. Horan,et al.  CT Chest is a Waste of Resources in the Staging of Seminoma of the Testis , 2007 .

[18]  S. Fosså,et al.  Late relapses of germ cell malignancies: incidence, management, and prognosis. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  F. V. van Leeuwen,et al.  Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  J. Carles,et al.  Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  John D Boice,et al.  Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. , 2005, Journal of the National Cancer Institute.

[22]  G. Rustin,et al.  Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial , 2005, The Lancet.

[23]  A. Sigurdson,et al.  International patterns and trends in testis cancer incidence , 2005, International journal of cancer.

[24]  C. Catton,et al.  Should surveillance be considered the standard of care in stage I seminoma , 2005 .

[25]  C. Bokemeyer,et al.  FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residuals. , 2005, European journal of radiology.

[26]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[27]  S. Fosså,et al.  Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I Testicular Seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328). , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  C. Catton,et al.  Stage II testicular seminoma: patterns of recurrence and outcome of treatment. , 2004, European urology.

[29]  C. Meisner,et al.  Para-aortic irradiation for stage I testicular seminoma: results of a prospective study in 675 patients. A trial of the German testicular cancer study group (GTCSG) , 2004, British Journal of Cancer.

[30]  G. Mikuz,et al.  Handling and reporting of biopsy and surgical specimens of testicular cancer. , 2004, European urology.

[31]  Andrew K. Lee,et al.  Mortality after cure of testicular seminoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  J. Logue,et al.  Short course para-aortic radiation for stage I seminoma of the testis. , 2003, International journal of radiation oncology, biology, physics.

[33]  L. Livi,et al.  Stage I seminoma of the testis: a bi‐institutional retrospective analysis of patients treated with radiation therapy only , 2003, BJU international.

[34]  B. Leibovich,et al.  Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity? , 2003, The Journal of urology.

[35]  D P Dearnaley,et al.  Cardiovascular disease as a long-term complication of treatment for testicular cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  C. Meisner,et al.  Radiotherapy for stages IIA/B testicular seminoma: final report of a prospective multicenter clinical trial. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  G. Daugaard,et al.  Surveillance in stage I testicular cancer , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[38]  M. Climent,et al.  Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis: the experience of the Spanish Germ-Cell Cancer Group (GG). , 2002, European urology.

[39]  A. Horwich,et al.  Prognostic Factors for Relapse in Stage I Seminoma Managed by Surveillance: A Pooled Analysis , 2002 .

[40]  A. Pollack,et al.  Radiotherapy for stage II testicular seminoma. , 2001, International journal of radiation oncology, biology, physics.

[41]  L. Einhorn,et al.  Positron emission tomography scans in the evaluation of postchemotherapy residual masses in patients with seminoma. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  L. Collette,et al.  Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma. European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working Party. , 1999, Journal of the National Cancer Institute.

[43]  S. Fosså,et al.  Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial. Medical Research Council Testicular Tumor Working Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  R. Miralbell,et al.  Seminoma of the testis: is scrotal shielding necessary when radiotherapy is limited to the para-aortic nodes? , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[45]  A. Horwich,et al.  Radiotherapy after chemotherapy for metastatic seminoma--a diminishing role. MRC Testicular Tumour Working Party. , 1997, European journal of cancer.

[46]  S. Fosså,et al.  External beam abdominal radiotherapy in patients with seminoma stage I: field type, testicular dose, and spermatogenesis. , 1997, International journal of radiation oncology, biology, physics.

[47]  R. Motzer,et al.  Surgery for a post-chemotherapy residual mass in seminoma. , 1997, The Journal of urology.

[48]  S. Culine,et al.  Optimal management of residual mass after chemotherapy in advanced seminoma: there is time for everything. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  G. Kerr,et al.  Radiotherapy for stages I and II testicular seminoma: results and morbidity in 238 patients. , 1995, The British journal of radiology.

[50]  A. Stiggelbout,et al.  Second cancer risk following testicular cancer: a follow-up study of 1,909 patients. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  W. van Putten,et al.  Orchidectomy followed by radiotherapy in 176 stage I and II testicular seminoma patients: benefits of a 10-year follow-up study. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[52]  Leslie H. Sobin,et al.  TNM Classification of Malignant Tumours, 7th Edition , 2009 .

[53]  A. Calvert,et al.  Carboplatin dosing formulae: gender bias and the use of creatinine-based methodologies. , 2002, European journal of cancer.

[54]  U. Pichlmeier,et al.  Adjuvant treatment of clinical stage I seminoma: is a single course of carboplatin sufficient? , 2000, Urology.

[55]  R. Coleman,et al.  The management and clinical course of testicular seminoma: 15 years' experience at a single institution. , 1998, Clinical oncology (Royal College of Radiologists (Great Britain)).

[56]  D. Dearnaley,et al.  Residual mass following chemotherapy of seminoma. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

[57]  M. Ro̸rth,et al.  Surveillance following orchidectomy for stage I seminoma of the testis. , 1993, European journal of cancer.

[58]  S. Kjaer,et al.  Survival of Danish cancer patients 1943-1987. Female genital organs. , 1993, APMIS. Supplementum.